Related Experiment Video

Updated: May 13, 2026

Quantitative Autonomic Testing
11:40

Quantitative Autonomic Testing

Published on: July 19, 2011

Evaluation of the autonomic function in patients with hypertrophic cardiomyopathy with and without syncope

Milena Frota Macatrão-Costa1, Edmundo Arteaga-Fernandez, Fábio Sandoli de Brito

  • 1Instituto do Coração, Hospital das Clínicas, FM, USP, São Paulo, SP, Brasil. milenamacatrao@cardiol.br

Insights

Patients with hypertrophic cardiomyopathy and unexplained syncope show reduced parasympathetic activity. Autonomic function testing, including head-up tilt, has limited value in diagnosing syncope in this population.

Area of Science:

  • Cardiology
  • Autonomic Neuroscience
  • Medical Diagnostics

Background:

  • Hypertrophic cardiomyopathy (HCM) patients may experience syncope due to hemodynamic collapse, potentially linked to autonomic imbalance.
  • Understanding autonomic function is crucial for managing syncope in HCM.

Purpose of the Study:

  • To compare autonomic function in HCM patients with unexplained syncope (US) versus those without syncope.
  • To assess the utility of baroreflex sensitivity (BRS) and heart rate variability (HRV) in differentiating these groups.

Main Methods:

  • Autonomic function was evaluated in 37 HCM patients (16 with US, 21 without) using spontaneous and phenylephrine-induced BRS.
  • Heart rate variability (HRV) was analyzed in time and frequency domains during 24-hour Holter monitoring and head-up tilt (HUT) tests.

Main Results:

  • No significant differences in spontaneous or phenylephrine-induced BRS, or overall HRV (SDNN) were found between groups.
  • HCM patients with US exhibited significantly lower parasympathetic indicators (RMSSD, pNN50, and high-frequency HRV) compared to controls.
  • Head-up tilt (HUT) testing showed poor sensitivity and specificity for identifying the cause of syncope in this cohort.

Conclusions:

  • HCM patients with unexplained syncope demonstrate reduced parasympathetic tone, though its clinical significance requires further investigation.
  • Head-up tilt (HUT) testing is not a reliable diagnostic tool for evaluating syncope etiology in HCM patients due to low specificity.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...